Treatment of Blepharospasm, and Cervical Dystonia

被引：0
|
作者：
Jankovic, J. [1 ]
机构：
[1] Baylor Coll Med, Houston, TX 77030 USA
来源：
MOVEMENT DISORDERS | 2010年 / 25卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：S585 / S585
页数：1
相关论文
共 50 条
  • [41] Pooled Safety Analysis of Randomized, Prospective Studies on IncobotulinumtoxinA for the Treatment of Cervical Dystonia, Blepharospasm, and Upper Limb Spasticity
    Simpson, David
    Hast, Michael
    Hanschmann, Angelika
    NEUROLOGY, 2018, 90
  • [42] Cortico-Subcortical White Matter Bundle Changes in Cervical Dystonia and Blepharospasm
    Gianni, Costanza
    Piervincenzi, Claudia
    Belvisi, Daniele
    Tommasin, Silvia
    De Bartolo, Maria Ilenia
    Ferrazzano, Gina
    Petsas, Nikolaos
    Leodori, Giorgio
    Fantoni, Nicoletta
    Conte, Antonella
    Berardelli, Alfredo
    Pantano, Patrizia
    BIOMEDICINES, 2023, 11 (03)
  • [43] BOTULINUM TOXIN IN BLEPHAROSPASM, HEMIFACIAL SPASM AND CERVICAL DYSTONIA - RESULTS IN 33 PATIENTS
    NOVIS, SAP
    DEMATTOS, JP
    DEROSSO, ALZ
    ARQUIVOS DE NEURO-PSIQUIATRIA, 1995, 53 (3A) : 403 - 410
  • [44] COST-EFFECTIVENESS OF INCOBOTULINUMTOXIN-A WITH FLEXIBLE TREATMENT INTERVALS COMPARED TO FIXED TREATMENT INTERVALS IN THE MANAGEMENT OF BLEPHAROSPASM AND CERVICAL DYSTONIA
    Tilden, D.
    Guarnieri, C.
    VALUE IN HEALTH, 2016, 19 (07) : A433 - A433
  • [45] A Prospective, Observational Trial Evaluating Xeomin [IncobotulinumtoxinA] for Cervical Dystonia or Blepharospasm in the US - Preliminary Baseline Results for Patients with Blepharospasm
    LeDoux, Mark S.
    Jankovic, Joseph
    Sethi, Kapil D.
    Verma, Amit
    Pappert, Eric J.
    Fernandez, Hubert H.
    ANNALS OF NEUROLOGY, 2012, 72 : S102 - S103
  • [46] POOLED SAFETY ANALYSIS OF RANDOMIZED, PROSPECTIVE STUDIES ON INCOBOTULINUMTOXINA FOR THE TREATMENT OF CERVICAL DYSTONIA, BLEPHAROSPASM, AND UPPER-LIMB SPASTICITY
    Simpson, David M.
    Hast, Michael A.
    Hanschmann, Angelika
    TOXICON, 2018, 156 : S105 - S105
  • [47] COST-EFFECTIVENESS OF INCOBOTULINUMTOXIN-A WITH FLEXIBLE TREATMENT INTERVALS COMPARED TO ONABOTULINUMTOXIN-A IN THE MANAGEMENT OF BLEPHAROSPASM AND CERVICAL DYSTONIA
    Tilden, D.
    Guarnieri, C.
    Jackson, D.
    VALUE IN HEALTH, 2015, 18 (07) : A759 - A759
  • [48] Cost-Effectiveness of Incobotulinumtoxin-A with Flexible Treatment Intervals Compared to Onabotulinumtoxin-A in the Management of Blepharospasm and Cervical Dystonia
    Tilden, Dominic
    Guarnieri, Carmel
    VALUE IN HEALTH, 2016, 19 (02) : 145 - 152
  • [49] XCiDaBLE, a phase IV, observational, prospective trial evaluating incobotulinumtoxin A (XEOMIN®) for cervical dystonia or blepharospasm: preliminary baseline results for subjects with cervical dystonia
    Truong, D.
    Danisi, F.
    Sethi, K.
    Verma, A.
    Pappert, E. J.
    Fernandez, H. H.
    EUROPEAN JOURNAL OF NEUROLOGY, 2012, 19 : 667 - 667
  • [50] Xeomin® in the treatment of cervical dystonia
    Benecke, R.
    EUROPEAN JOURNAL OF NEUROLOGY, 2009, 16 : 6 - 10
12345